Binding of high-avidity anti-β2-glycoprotein I antibodies

被引:14
|
作者
Cucnik, S
Kveder, T
Rozman, B
Bozic, B
机构
[1] Univ Ljubljana, Med Ctr, Dept Rheumatol, Ljubljana 1000, Slovenia
[2] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia
关键词
anti-beta 2-glycoprotein I antibodies; Fab fragments; avidity; affinity; antiphospholipid syndrome; systemic lupus erythematosus;
D O I
10.1093/rheumatology/keh349
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. We studied the influence of different binding conditions on the interaction between high- or low-avidity IgG anti-beta(2)-glycoprotein I antibodies (anti-beta(2)-GPI) and beta(2)-GPI, which was either free in solution or bound to microtitre plates or nitrocellulose membranes. Methods. Sera from 30 patients with antiphospholipid syndrome and/or systemic lupus erythematosus were selected on the basis of anti-beta(2)-GPI positivity. Avidity of IgG anti-beta(2)-GPI was determined by chaotropic ELISA, using increased NaCl concentration during the antibody binding. Immunodetection on nitrocellulose membrane followed reducing or non-reducing sodium dodecyl sulphate-polyacrylamide gel electrophoresis (PAGE) of beta(2)-GPI. In converted, non-reducing PAGE, the preparation with high-affinity Fab fragments (obtained by papain digestion) was subjected to electrophoresis, while purified beta(2)-GPI was used as the sample in immunodetection. Results. Anti-beta(2)-GPI antibodies of high, low or heterogeneous (low and high) avidity were found in 5/30, 9/30 and 16/30 sera, respectively. The density of beta(2)-GPI, which was 20-30 times higher on the nitrocellulose membrane than on the surface of ELISA plates, was not sufficient for the recognition of the antigen by anti-beta(2)-GPI: 2/5 high-avidity samples reacted only with non-reduced beta(2)-GPI, 3/9 low-avidity samples recognized only denatured and reduced beta(2)-GPI, and 1/16 samples with heterogeneous-avidity antibodies reacted with reduced and non-reduced beta(2)-GPI. Conclusions. Our results suggest that neither high density of the antigen nor high avidity of the antibodies (or Fab fragments) alone was sufficient for the binding of anti-beta(2)-GPI to beta(2)-GPI. Some conformational modifications and, consequently, exposed neo-epitopes are required for the recognition of beta(2)-GPI by polyclonal anti-beta(2)-GPI antibodies.
引用
收藏
页码:1353 / 1356
页数:4
相关论文
共 50 条
  • [21] β2-glycoprotein I, anti-β2-glycoprotein 1, and fibrinolysis
    Yasuda, S
    Atsumi, T
    Ieko, M
    Koike, T
    THROMBOSIS RESEARCH, 2004, 114 (5-6) : 461 - 465
  • [22] Anti-β2-glycoprotein I antibodies in children with atopic dermatitis
    Ambrozic, A
    Avicin, T
    Ichikawa, K
    Kveder, T
    Matsuura, E
    Hojnik, M
    Atsumi, T
    Rozman, B
    Koike, T
    INTERNATIONAL IMMUNOLOGY, 2002, 14 (07) : 823 - 830
  • [23] Avidity of anti-β2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome
    Cucnik, S
    Bozic, B
    Kveder, T
    Tomsic, M
    Rozman, B
    AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 : 141 - 147
  • [24] Significance of anticardiolipin and anti-β2-glycoprotein I antibodies in lupus nephritis
    Loizou, S
    Samarkos, M
    Norsworthy, PJ
    Cazabon, JK
    Walport, MJ
    Davies, KA
    RHEUMATOLOGY, 2000, 39 (09) : 962 - 968
  • [25] Prevalence of anticardiolipin and anti-β2-glycoprotein I antibodies in celiac disease
    Karoui, Sami
    Sellami, Maryam Kallel
    Laatar, Asma Belkhodja
    Zitouni, Mondher
    Matri, Samira
    Laadhar, Lilia
    Fekih, Monia
    Boubaker, Jalel
    Makni, Sondes
    Filali, Azza
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (04) : 1096 - 1100
  • [26] Pathogenic anti-β2-glycoprotein I antibodies recognize domain I of β2-glycoprotein I only after a conformational change
    de Laat, B
    Derksen, RHWM
    van Lummel, M
    Pennings, MTT
    de Groot, PG
    BLOOD, 2006, 107 (05) : 1916 - 1924
  • [27] Anti-β2-glycoprotein I antibodies bind to central nervous system
    Caronti, B
    Pittoni, V
    Palladini, G
    Valesini, G
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 156 (02) : 211 - 219
  • [28] Prevalence of Anticardiolipin and Anti-β2-Glycoprotein I Antibodies in Celiac Disease
    Sami Karoui
    Maryam Kallel Sellami
    Asma Belkhodja Laatar
    Mondher Zitouni
    Samira Matri
    Lilia Laadhar
    Monia Fekih
    Jalel Boubaker
    Sondes Makni
    Azza Filali
    Digestive Diseases and Sciences, 2007, 52 : 1096 - 1100
  • [29] The avidity of anti-β2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies
    Cucnik, S.
    Kveder, T.
    Ulcova, G. Z.
    Swadzba, J.
    Musial, J.
    Valesini, G.
    Avcin, T.
    Rozman, B.
    Bozic, B.
    LUPUS, 2011, 20 (11) : 1166 - 1171
  • [30] Effect of anti-β2-glycoprotein I and anti-prothrombin antibodies on platelet activation
    Ruggeri, L
    Galli, M
    Barbui, T
    THROMBOSIS AND HAEMOSTASIS, 1999, : 101 - 102